Use of recombinant human bone morphogenetic protein for revision cervical spine fusion in children with Down syndrome: a case series.
Cohen LL, Yang BW, O'Neill NP, Proctor MR, Glotzbecker MP, Hedequist DJ. Use of recombinant human bone morphogenetic protein for revision cervical spine fusion in children with Down syndrome: a case series. Journal Of Neurosurgery Pediatrics 2020, 25: 535-539. PMID: 32005018, DOI: 10.3171/2019.11.peds19622.Peer-Reviewed Original ResearchCervical spine fusionSpine fusionAtlantoaxial instabilityRecombinant human bone morphogenetic protein-2Postoperative complicationsCase seriesFirst case seriesLength of stayIliac crest boneSolid fusion massNeurological deteriorationCervical fusionLast radiographRetrospective reviewDural tearPosterior fusionPseudarthrosis rateSurgical dataHalo useRevision surgeryImplant revisionCrest boneDS populationInclusion criteriaRecombinant human bone morphogenetic protein